Abstract-This paper presents the Total Mass Target Controlled Infusion algorithm. The system comprises an On Line tuned Algorithm for Recovery Detection (OLARD) after an initial bolus administration and a Bayesian identification method for parametric estimation based on sparse measurements of the accessible signal. To design the drug dosage profile, two algorithms are here proposed. During the transient phase, an Input Variance Control (IVC) algorithm is used. It is based on the concept of TCI and aims to steer the drug effect to a predefined target value within an a priori fixed interval of time. After the steady state phase is reached the drug dose regimen is controlled by a Total Mass Control (TMC) algorithm. The mass control law for compartmental systems is robust even in the presence of parameter uncertainties. The whole system feasibility has been evaluated for the case of Neuromuscular Blockade (NMB) level and was tested both in simulation and in real cases.
I. INTRODUCTION
Automation in biomedicine plays an important role in the improvement of health care, which claims for robust and secure technologies. This is particularly true when we want to determine and apply the adequate drug dosage regimen to each patient. In general anaesthesia environment, the major difficulty concerning the drug dose administration is the high level of uncertainty in the model relating the manipulated variable (amount of drug) and the choice of the adequate sensor our even process variable (for instance the neuromuscular blockade level, NMB, or the depth of anaesthesia evaluated by brain bispectral index of unconsciousness, BIS).
Although the structure of the pharmacokinetic/pharmacodynamic (PK/PD) models is relatively well known, there is a high parameter variability from patient to patient that suggests the use of adaptive methods both for identification and control purposes. Trying to solve the patient identification problem and the control of drug dose administration, several approaches have recently being developed [1] , [2] . Actually, Target Controlled Infusion (TCI) strategies are commonly accepted and used due to its specific features. TCI allows for a controlled infusion in such a manner as to attempt to achieve a user-defined drug concentration in a body compartment or tissue of interest [3] . In order to reach that PD concentration, the dose profile is predicted by validated population models. Therefore, these open-loop control devices do not compensate for a mismatch between the models and the patient dynamics and they are not completely adequate for drug administration [4] .
This study presents the development of an integrated control algorithm that deal with the need for adaptation in TCI. The proposed control strategy computes the adequate drug dosage regimen that drives the drug effect to a desired target in a specified period of time and determines the loading dose that should be administered to control the system around that working point.
The global algorithm architecture also incorporates a identification method based on a Bayesian optimization for parameter identification and a on-line tuned algorithm for recovery detection [5] . The implementation of the whole system controller is here illustrated by a case study, the closed-loop control of Neuromuscular Blockade (NMB) with the muscle relaxant atracurium.
The remainder of the paper is structured as follows: the NMB model structure together with the identification algorithm are defined in Sections II-A and II-B. The online tuned algorithm for recovery detection is summarized in Section II-C. The input variance control algorithm and total-mass control algorithm are explained in detail in Sections II-D and II-E. Some simulation results for the NMB case-study are given and discussed in Section III, also with one real case where the system has been tested. A brief summary of the main proposed advances concludes the paper (Section IV).
II. ADAPTIVE TCI STRATEGY

A. Neuro Muscular Blockade Model
The dynamic response of NMB for several muscle relaxants may be modeled by a Wiener structure: a linear part followed by a non-linear static dynamic one. For the muscle relaxant atracurium the resulting equations are the following:
The linear PK part relates the drug infusion rate u(t) [µg kg
A single bolus of u 0 , given at t = 0 min (induction phase) may be described by u(t) = u 0 δ(t) µg kg −1 . For atracurium, the typical bolus is of 500 µg kg −1 . The pharmacodynamic part (PD) embodies to different blocks. The first one is linear and relates c p (t) with the effect concentration c e (t)[µg ml −1 ] (2). The second one comprises a non-linear static Hill relationship between c e (t) and the NMB level r(t) [%] (3). The vector Θ incorporates the patient dependent parameters:
Remark that in practice the intermediate signal c e (t) is not accessible, therefore its estimated value, c e (Θ, t) is considered.
The NMB level of a patient is typically quantified between 0% (full paralysis) and 100% (full muscular activity). For control purposes, during the period where the bolus is acting, the value of the reference is fixed at a low level, being gradually raised to the set-point r * (typically 10%) in order to avoid sudden changes, stabilizing on this value after minute 75 ( when steady-state is assumed to be attained) [6] .
In order to cover a wide range of behaviours, a bank of nonlinear dynamic models
..,100 } was generated using the probabilistic model discussed in [7] .
Since the average parameters do not convey information regarding the spread of the individual values, it is reasonable that the use of additional information on the inter individual variability of the PK/PD parameters may lead to techniques achieving improved results.
B. PK/PD Bayesian Identification
According to this Bayesian approach, when a measurement of the response signal r(t) is available, the estimates of the patient PK/PD parameters are actualized by minimizing the following Bayesian objective cost function, which assumes an underlying log-normal distribution for Θ [8] ,
The vector Θ = [θ 1 , θ 2 , · · · , θ m ] represents the PK/PD for some population model andΘ = [θ 1 ,θ 2 , · · · ,θ m ], (with m = 7, because for C 50 the mean population value has been used [9] ) stands for the individual patient identified parameterization; u(t) is the dosage regimen; T (t k ) is a function of the NMB measured signal at time t k ; T (t k ; u,Θ) is the predicted at time t k induced by u(t) on the patient model with parameter vector Θ; σ 2 j is the variance of the logarithmic distribution assumed for the population PK/PD parameter θ j ; and σ 2 k describes the variance of the error on the measurement of the individual NMB signal at t = t k .
C. The On Line tuned Algorithm for Recovery Detection -OLARD
Considering an automated drug dose administration, it should be noted that the time evolution of the measured response r(t) is highly dependent on the time instant t 0 that is chosen to start the continuous drug infusion u(t) after the bolus administration. Therefore, the on-line detection of the initial recovery t 0 is of outstanding importance and it may be used as a decision flag, alarm or advisory component in an automatic drug delivery setup.
During the induction phase, the proposed On Line tuned Algorithm for Recovery Detection (OLARD) initially computes an adequate and individual detection baseline in order to overcome a variety of sensor drawbacks. Thereafter, the detection of the NMB recovery from the initial bolus administration is computed through an empirical algorithm that has been developed taking into account the baseline and the characteristics of the signal under analysis. The algorithm parameters were tuned both in simulation using the model bank M and in real cases previously collected during monitoring or control procedures in patients undergoing general anaesthesia. In order to achieve a robust and reliable performance, the set of default parameters can be adjusted on line, taking into account the predicted degree of patient variability and the level of sensor noise, as well as the clinic experience about the system environment.
D. Input Variance Control algorithm -IVC
The Input Variance Control algorithm (IVC) was designed to control the system in the transient phase [t 0 , t 1 ], where t 0 is the previously identified recovery time and t 1 is the instant time where steady-state is assumed to be reached, i.e., r(t 1 ) = r * . The IVC approach designs an optimal dose regimen profile for steering the NMB level from its value r(t 0 ) at t 0 to the defined target r(t 1 ) = r * at t 1 . Assuming linear time-invariant dynamics, the PK/PD system drug response (1,2) may be modeled by the following discrete-time state-space system:
where u(t) ∈ R is the input (piecewise constant drug dose infusion), x(t) ∈ R n×1 the state-vector, y(t) ∈ R is the output (effect concentration of the drug), C ∈ R 1×n , Φ ∈ R n×n and Γ ∈ R n×1 (with n equal to the system order). It should be stressed that Φ and Γ are dependent on the values of Θ. This dependence on the parameters is here omitted only for the sake of simplicity. Given an initial time t 0 , an initial state x(t 0 ) = X 0 , and an input signal u(t) defined for all t, a solution of (6) for t > t 0 is given by [10] :
where φ(i, j) = Φ i−j for i ≥ j + 1. The evolution of the system from t 0 (the beginning of drug infusion) to t 1 = t 0 + p (the time when the steady-state is supposed to be reached) can then be represented by
where
The reference profile in the effect concentration is obtained from the a priori fixed c * e (t 1 ) = f 
Making Y = c * e in (8) , and in order to avoid too large control signals and syringe pump saturation, a variance constrained input strategy was developed based on [11] .
From (1,2), it turns out that the steady-state drug dose, u ss , is a non linear function of the PK/PD parameters and of the NMB target value. Using straightforward calculations,
An incremental version of the algorithm is proposed in order to obtain the adequate u ss (Θ, t). Hence, (8) is modified into The adaptive control problem can then be formulated as follows.
where ρ is as a Lagrange multiplier satisfying
Note that, in each time instant the patient response r(t) is measured after applying u(t 0 ) = u ss + ∆u(t 0 ) corresponding to the first value of the obtained optimal drug regimen (U = U ss +∆U ). Thereafter, inverting the Hill equation (3)
E. Total-mass control algorithm -TMC
For practical purposes and without loss of generality, the identification procedure is stopped as soon as the parameters are assumed to be reasonably identified and the reference signal attains the predefined value r * = 10%. It turns out that in order to avoid computational bender, from this time instant the individual patient parameterization is assumed to be fixed. Neverthless, it is possible to trigger on-line the identification procedure in order to obtain, whenever considered necessary, a more accurate parameter estimation.
From this point on, the control strategy switches to a mass control scheme which has proved to have good robustness properties under the presence of uncertainties [12] . For this purpose the patient is modelled as a three-compartmental system. The drug infusion dose u(t) is administered in the central compartment, according to the following law,
where M (m) = i=1,2,3 m i and m = (m 1 , m 2 , m 3 ) T . m i is the amount of drug in compartment i and q i ≥ 0 is a rate constant such that q i m i is the flow rate from compartment i to the environment. The values of q i as well as the initial values of m i , i = 1, 2, 3, are obtained from the previously estimated parameters. M * is the value for the total amount of drug in the three compartments, computed in such a way that the corresponding effect concentration yields the target value of r * for neuromuscular blockade [12] . Since the parameters q i 's are affected by an estimation error, a steady state error will occur. Indeed, denoting the error of q i by ∆q i , the previous control law becomes
and it is shown in [12] . When the drug infusion dose u(t) is administered in the central compartment, according to this law, the amount of drug in each compartment will converge to a value that depends on ∆q i 's. According to the robustness analysis that was made in [12] , the decreasing of the values ∆q i , i = 1, 2, 3, would correspond to the decreasing of the steady state error. However, ∆q 1 , ∆q 2 and ∆q 3 are fixed, after the beginning of this control scheme. Therefore, in order to reduce the steady state error, we redesign the mass control law, by replacing the original value of M * by another one, computed based on information about the obtained steady state error. A more complete description of this strategy will be given elsewhere. 
III. RESULTS
With the purpose of testing the global approach comprising the dedicated identification and control algorithms previously described, simulation studies have been carried out using the model bank M. After the typical bolus administration, the NMB level decreases very quickly and full paralysis is induced in a few minutes (clinical requirement). After the induction period, the control purpose is to follow a specific reference profile to reach a predefined target value. Fig. 1 and 2 illustrate the filtered response, the target value and the administered drug dose profile for patient M 60 ∈ M after control with the Total Mass TCI strategy. In Fig. 1 , and in order to highlight the algorithm performance, the exact parameterization of the simulated patient (Θ = Θ M60 ) was assumed to be known. The NMB response is represented with a maximum value of 30% to illustrate the reference tracking in detail. The dot indicates the estimated beginning of recovery according to OLARD specifications, and the instant time t 0 is thereafter used as the decision flag to enable the start of the atracurium continuous infusion. After the t 0 identification, the NMB level is driven, by IVC strategy, from r(t 0 ) to the target value r(t 1 = 75min) = r * = 10%. Afterwards, the TMC is applied to control the system by designing the adequate drug dose profile that sustains the system total mass in the value M * , corresponding to r * (t) = 10%. By analyzing Fig. 1 and 2, TMC strategy had driven the NMB level to a value bellow 10%. The response exhibits a negleted constant steady state error since the existence of parameters uncertainties (∆q i = 0) has been assumed to be present. For the case illustrated in Fig. 2 , during the transient period [t 0 , t 1 ], the patient parameters were identified every 3 minutes by the identification Bayesian algorithm. Parameters evolution over time is shown in Fig. 3 being the values normalized by the true value of each one (Θ/Θ 60 ). Notice that the last two parameter refinement procedures do not introduce relevant additional information about the system dynamics. Moreover, apart from parameters λ 1 and λ 2 that have been accurately identified, the other parameters present an identification error less that 10%. Remark that, in this case, during the identification procedure the majority of the parameters present a smooth trajectory from the initial guess to their final estimates, whereas the parameter a 1 presents a significant variation (in accordance with the typical scenario observed in the model bank M).
The NMB level r(t) presents an overshoot after the beginning of continuous infusion. This can be explained by the fact that the drug profile initially calculated through IVC algorithm relies on initial 'rough' parameter estimates. However, it can be clearly observed that, with the improvement of the parameter estimates during the transient period, the drug dose rate profile is being updated accordingly, driving the NMB value to the desired target. Afterward, TMC strategy sustained the continuous infusion and brought the NMB level to a value near 8%. This negleted constant steady state error is due to the use of parameter estimates, as referred before. Fig. 4 represents M * (Θ f inal ). The desired value for the total mass of the system (solid line) and the time evolution of (M (m)), the current total mass (in dashed line). At the time instant indicated by the arrow the control law was changed from (13) to the referred redesigned mass control law, by replacing the original value of M * by another one, computed based on information about the obtained steady state error. The total mass convergence is then modified and the total mass then was been driven to the target value of M * .
The Total Mass TCI strategy was recently integrated in the software Hippocrates [13] and it is under evaluation on patients undergoing general anaesthesia. Fig. 5 illustrates the first case so far obtained on a patient undergoing elective surgery. The clinical performance was considered satisfactory in spite of the steady-state error observed during the control with the TMC algorithm. The filtered NMB signal indicates the presence of sensor noise superimposed on the measured signal. The estimated recovery time according to OLARD specifications was considered correct by the clinician. Time parameter evolution is shown in Fig. 6 being the values normalized by the population parameterization values (Θ/Θ). Notice that, as in the reported simulated cases, the last two parameter refinement procedures do not introduce relevant additional information about the system dynamics. Moreover, in the real case, some of the parameters present significant variations from the population parameters. In Fig. 7 is represented M * (Θ f inal ), the desired value for the total mass of the system (solid line) and the time evolution of (M (m)), the current total mass (in dashed line). The total mass convergence presents a similar behaviour with the reported simulated cases. Total mass evolution for the real control case. In solid line is represented the target level in total mass (M * (Θ f inal )); in dashed line is represented the time evolution of the system total mass (M (m)); in dots is represented the different values of M * (Θ k ) in the transient phase.
IV. CONCLUSIONS
Total Mass Target Controlled Infusion System (TCI) is an integrated algorithm for automatic drug administration described in this paper. The developed scheme comprises individual identification parameters driven by a Bayesian optimization method coupled with a robust total mass control of compartmental systems in the presence of parameters uncertainties.
The performance of the developed strategy was evaluated in the NMB (NeuroMuscular Blockade) control. This particular application enables quite accurate evaluation of an automatic control delivery system, since the sensor is widely accepted in clinical environment. The proposed Total Mass TCI strategy comprises three different stages. After the initial bolus administration there is no extra dose administered to the patient until the detection of the recovery time t 0 , carried out by a dedicated developed detection algorithm, OLARD (On Line tuned Algorithm for Recovery Detection). During the transient phase, an identification Bayesian method together with an iterative version of an Input Variance Control (IVC) algorithm is used to calculate the optimal dose profile to attain steady state within a defined interval of time. Moreover, the Bayesian algorithm using sparse measurements of the signal has proved to obtain reliable estimation for the model parameters. Finally, driven by the parameter estimation, a Total Mass Control (TMC) scheme for compartmental systems, that exhibit robustness properties under the presence of parameters uncertainties, is applied to maintain the target value. The whole strategy was applied to a bank of models and demonstrated to be adequate to the design of individualized dose regimen both for open and closed loop systems, even in the presence of noise and uncertainties. The performance analysis in clinical environment is undergoing on patients under general anaesthesia.
The main results of this paper encourage the development of dedicated algorithms in order to obtain an enhanced and robust version of a Target Control Infusion prototype.
